Treatment of cutaneous forms of lupus erythematosus

On 19/09/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 481. The active ingredient is R-salbutamol sulphate for treatment of cutaneous forms of lupus erythematosus.